October 27, 2016
Bayer profit rises to €1,2 B in Q3 2016
The Bayer Group remained on a path of growth in the third quarter of 2016 and took a major step forward…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Business
October 27, 2016
Allergan: changes to board leadership
Allergan has announced changes to leadership roles within its board of directors.
October 27, 2016
Advanced Oncotherapy promotes Nicolas Serandour as new CEO
Advanced Oncotherapy has named Nicolas Serandour the new CEO…
October 26, 2016
Horizon completes acquisition of Raptor
Horizon Pharma has completed the acquisition of Raptor Pharmaceutical…
October 26, 2016
Novartis CEO sees tougher U.S. drug pricing over next three-five years
Novartis expects a more difficult pricing environment for drugs in…
October 25, 2016
Novartis’s Q3 2016 net income $10,9B shorter than last year
Novartis’s Q3 2016 net income $10,9B shorter than last year
October 25, 2016
Allergan completes acquisition of Vitae
Allergan successfully completed its tender offer to purchase …
October 24, 2016
Biophytis outsources AMD drug production to Patheon, USA
Biophytis has entered into an agreement with US firm Patheon for the industrial …
October 21, 2016
Ablynx announces warrant exercise
Ablynx today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an additional 10,050 common shares have been issued by the Company in exchange for EUR47,303 as the result of the exercise of warrants.
October 21, 2016
Premaitha Health issues 940,000 options
Premaitha Health has issued 940,000 options over ordinary shares under the Company’s unapproved share option scheme to two employees.